Glaucoma Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Glaucoma Surgery Devices Pipeline Market Report Overview

Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow.

The glaucoma surgery devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Glaucoma Drainage Devices

·       Minimally Invasive Glaucoma Surgery (MIGS) Devices

Key Territories ·       The United States

·       Europe

·       China

·       Israel

·       Canada

Key Regulatory Paths ·       PMA

·       510(k)

·       CE

·       NMPA

·       TGA

Leading Companies ·       Alievio Inc.

·       Allergan Ltd

·       Assenti, LLC

·       Avisi Technologies LLC

·       Chongqing Migos Medical Technology Co. Ltd.

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Buy the Full Report for More Insights into the Glaucoma Surgery Devices Pipeline Market

Download a Free Report Sample

Glaucoma Surgery Devices Pipeline Market Segments

The key segments in the glaucoma surgery devices pipeline market are glaucoma drainage devices and minimally invasive glaucoma surgery (MIGS) devices. Glaucoma drainage devices had the highest number of pipeline products in the glaucoma surgery devices pipeline market as of October 2024. They are small plastic devices that are surgically attached to the eye’s surface to improve or shunt the flow of aqueous drainage.

Glaucoma Surgery Devices Pipeline Market Analysis by Segments, 2024 (%)

Glaucoma Surgery Devices Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Glaucoma Surgery Devices Pipeline Market

Download a Free Report Sample

Glaucoma Surgery Devices Pipeline Market Segmentation by Territories

The United States (US), Europe, China, Israel, and Canada among others are a few of the key territories of the glaucoma surgery devices pipeline market. As of October 2024, the US accounted for the highest number of pipeline products.

Glaucoma Surgery Devices Pipeline Market Analysis by Territories, 2024 (%)

Glaucoma Surgery Devices Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Glaucoma Surgery Devices Pipeline Market

Download a Free Report Sample

Glaucoma Surgery Devices Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the glaucoma surgery devices pipeline products market are PMA, 510(k), CE, NMPA, and TGA. As of October 2024, PMA was the most followed pathway for pipeline products in the glaucoma surgery devices market.

Glaucoma Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Glaucoma Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Glaucoma Surgery Devices Pipeline Market

Download a Free Report Sample

Glaucoma Surgery Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the glaucoma surgery devices pipeline market are Alievio Inc., Allergan Ltd, Assenti, LLC, Avisi Technologies LLC, and Chongqing Migos Medical Technology Co. Ltd., among others.

Alievio Inc: Alievio Inc., headquartered in the US, is an innovative glaucoma medical device company that is developing the first personalized glaucoma treatment to stop vision loss.

Allergan Ltd: Allergan Ltd (Allergan), a subsidiary of AbbVie Inc., is a specialty pharmaceutical company that develops and markets branded pharmaceuticals, biosimilar, and over-the-counter (OTC) pharmaceutical products. The company offers products in the areas of eye care, medical esthetics, dermatology, central nervous system, and other categories. It sells its products to retailers, drug wholesalers, and distributors, including national retail drug and food store chains, mail-order retailers, hospitals, clinics, and other institutions.

Glaucoma Surgery Devices Pipeline Market Analysis by Companies, 2024
Glaucoma Surgery Devices Pipeline Market Analysis by Companies, 2024Buy the Full Report for More Company Insights into the Glaucoma Surgery Devices Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Glaucoma Surgery Devices Pipeline Market Segments Outlook (2024)

  • Glaucoma Drainage Devices
  • Minimally Invasive Glaucoma Surgery (MIGS) Devices

Glaucoma Surgery Devices Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • China
  • Israel
  • Canada

Glaucoma Surgery Devices Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • 510(k)
  • CE
  • NMPA
  • TGA

Scope

This report provides:

  • Extensive coverage of the glaucoma surgery devices under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of glaucoma surgery devices and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of glaucoma surgery devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Analyze the product’s current stage of development, territory, and estimated launch date.

Alievio Inc
Allergan Ltd
Assenti, LLC
Avisi Technologies LLC
Chongqing Migos Medical Technology Co Ltd
Ciliatech Therapeutics AG
Corneat Vision Ltd
Eye Sonix
Galaxy Ophthalmics Inc (Inactive)
Geuder AG
Glaucot Teknoloji AS
Glaukos Corp
Health Guard Biomed (Suzhou) Biomedical Technology Co Ltd
HiSilicon (Suzhou) Biomedical Technology Co Ltd
Iantrek Inc
InnFocus Inc
iScience Interventional Inc
iSTAR Medical SA
iVeena Delivery Systems Inc
Johns Hopkins University
Kytogenics Pharmaceuticals Inc
Liqid Medical (Pty) Ltd
Medtronic Plc
Meir Medical Center
Merz Anteis SA
MicroOptx Inc
Mingche Biotechnology (Suzhou) Co Ltd
Myra Vision Inc
Ocumatrx
OcuTherix Inc
OPKO Health Inc
OptoLight Vision Technology
Purdue University
Queen's University
Rheon Medical SA
Sight Sciences Inc
Stanford University
Suzhou Langmu Medical Technology Co Ltd
Tel Aviv University
The Chaim Sheba Medical Center
The University of Texas at Austin Division of Housing and Food Service
University of Colorado
University of Colorado Anschutz Medical Campus
University of Florida
University of Michigan
University of Oslo
Vivid White Pty Ltd
Westhouse Medical Services Plc (Inactive)

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Glaucoma Surgery Devices Overview

3 Products under Development

3.1 Glaucoma Surgery Devices – Pipeline Products by Stage of Development

3.2 Glaucoma Surgery Devices – Pipeline Products by Segment

3.3 Glaucoma Surgery Devices – Pipeline Products by Territory

3.4 Glaucoma Surgery Devices – Pipeline Products by Regulatory Path

3.5 Glaucoma Surgery Devices – Pipeline Products by Estimated Approval Date

3.6 Glaucoma Surgery Devices – Ongoing Clinical Trials

4 Glaucoma Surgery Devices – Pipeline Products under Development by Companies

4.1 Glaucoma Surgery Devices Companies – Pipeline Products by Stage of Development

4.2 Glaucoma Surgery Devices – Pipeline Products by Stage of Development

5 Glaucoma Surgery Devices Companies and Product Overview

5.1 Alievio Inc Company Overview

5.1.1 Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Allergan Ltd Company Overview

5.2.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.3 Assenti, LLC Company Overview

5.3.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.4 Avisi Technologies LLC Company Overview

5.4.1 Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

5.5 Chongqing Migos Medical Technology Co Ltd Company Overview

5.5.1 Chongqing Migos Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.6 Ciliatech Therapeutics AG Company Overview

5.6.1 Ciliatech Therapeutics AG Pipeline Products & Ongoing Clinical Trials Overview

5.7 Corneat Vision Ltd Company Overview

5.7.1 Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.8 Eye Sonix Company Overview

5.8.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview

5.9 Galaxy Ophthalmics Inc (Inactive) Company Overview

5.9.1 Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.10 Geuder AG Company Overview

5.10.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview

5.11 Glaucot Teknoloji AS Company Overview

5.11.1 Glaucot Teknoloji AS Pipeline Products & Ongoing Clinical Trials Overview

5.12 Glaukos Corp Company Overview

5.12.1 Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview

5.13 Health Guard Biomed (Suzhou) Biomedical Technology Co Ltd Company Overview

5.13.1 Health Guard Biomed (Suzhou) Biomedical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.14 HiSilicon (Suzhou) Biomedical Technology Co Ltd Company Overview

5.14.1 HiSilicon (Suzhou) Biomedical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.15 Iantrek Inc Company Overview

5.15.1 Iantrek Inc Pipeline Products & Ongoing Clinical Trials Overview

5.16 InnFocus Inc Company Overview

5.16.1 InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview

5.17 iScience Interventional Inc Company Overview

5.17.1 iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview

5.18 iSTAR Medical SA Company Overview

5.18.1 iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview

5.19 iVeena Delivery Systems Inc Company Overview

5.19.1 iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.20 Johns Hopkins University Company Overview

5.20.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

5.21 Kytogenics Pharmaceuticals Inc Company Overview

5.21.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 Liqid Medical (Pty) Ltd Company Overview

5.22.1 Liqid Medical (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.23 Medtronic Plc Company Overview

5.23.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

5.24 Meir Medical Center Company Overview

5.24.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.25 Merz Anteis SA Company Overview

5.25.1 Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview

5.26 MicroOptx Inc Company Overview

5.26.1 MicroOptx Inc Pipeline Products & Ongoing Clinical Trials Overview

5.27 Mingche Biotechnology (Suzhou) Co Ltd Company Overview

5.27.1 Mingche Biotechnology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.28 Myra Vision Inc Company Overview

5.28.1 Myra Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

5.29 Ocumatrx Company Overview

5.29.1 Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview

5.30 OcuTherix Inc Company Overview

5.30.1 OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview

5.31 OPKO Health Inc Company Overview

5.31.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview

5.32 OptoLight Vision Technology Company Overview

5.32.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview

5.33 Purdue University Company Overview

5.33.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview

5.34 Queen’s University Company Overview

5.34.1 Queen’s University Pipeline Products & Ongoing Clinical Trials Overview

5.35 Rheon Medical SA Company Overview

5.35.1 Rheon Medical SA Pipeline Products & Ongoing Clinical Trials Overview

5.36 Sight Sciences Inc Company Overview

5.36.1 Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.37 Stanford University Company Overview

5.37.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview

5.38 Suzhou Langmu Medical Technology Co Ltd Company Overview

5.38.1 Suzhou Langmu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.39 Tel Aviv University Company Overview

5.39.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview

5.40 The Chaim Sheba Medical Center Company Overview

5.40.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.41 The University of Texas at Austin Division of Housing and Food Service Company Overview

5.41.1 The University of Texas at Austin Division of Housing and Food Service Pipeline Products & Ongoing Clinical Trials Overview

5.42 University of Colorado Company Overview

5.42.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

5.43 University of Colorado Anschutz Medical Campus Company Overview

5.43.1 University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview

5.44 University of Florida Company Overview

5.44.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview

5.45 University of Michigan Company Overview

5.45.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

5.46 University of Oslo Company Overview

5.46.1 University of Oslo Pipeline Products & Ongoing Clinical Trials Overview

5.47 Vivid White Pty Ltd Company Overview

5.47.1 Vivid White Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.48 Westhouse Medical Services Plc (Inactive) Company Overview

5.48.1 Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

6 Glaucoma Surgery Devices- Recent Developments

6.1 Sep 23, 2024: OPKO Health’s ModeX Therapeutics Names Giovanni Abbadessa as Chief Medical Officer

6.2 Sep 17, 2024: Iantrek Announces 1-Year Clinical Results of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients

6.3 Sep 11, 2024: Iantrek Announces Publication of Results of its Bio-interventional Uveoscleral Outflow Technology in Patients with Open-Angle Glaucoma

6.4 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.5 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.6 Aug 22, 2024: Eyebright Medical Technology Reports Financial Results for H1 of 2024

6.7 Aug 20, 2024: Alcon Announces Results for Three and Six Month Periods Ending June 30, 2024

6.8 Jun 14, 2024: Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its

2.75% Convertible Senior Notes Due 2027 for Common Stock

6.9 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.10 May 30, 2024: New World Medical Receives FDA 510(k) Clearance for KDB GLIDE

6.11 May 28, 2024: Sight Sciences Announces Publication Of A New Analysis From The Romeo Study Showing Meaningful Pressure And Medication Reductions Achieved With Omni Across Mild, Moderate, And Advanced Glaucoma

6.12 May 01, 2024: Myra Vision’s Calibreye Titratable Glaucoma Therapy Surgical System Showcased at Ophthalmology Conferences, Receiving Best Paper Award and Recognition of Future Promise in Glaucoma Care

6.13 Apr 29, 2024: Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery

6.14 Apr 10, 2024: Sight Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years

6.15 Apr 04, 2024: STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024

6.16 Apr 02, 2024: Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

6.17 Apr 01, 2024: Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting

6.18 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.19 Mar 12, 2024: Queen’s Appoints Next Board of Trustees chair

6.20 Mar 06, 2024: STAAR Surgical to Participate in Two Upcoming Investor Conferences

6.21 Feb 14, 2024: Sight Sciences Announces European Launch of the Ergo-Series of the OMNI Surgical System at the ESCRS Winter Meeting

6.22 Jan 24, 2024: Iridex Announces First Patient Enrollment in MicroPulse TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

6.23 Jan 10, 2024: iSTAR Medical Expands International Commercial Rollout of MINIject with Successful First Implants Completed in Australia

6.24 Dec 28, 2023: Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

6.25 Dec 26, 2023: Istar Medical Introduces Glaucoma Treatment Device in Netherlands

6.26 Dec 22, 2023: istar Medical Continues European Expansion with First Miniject Surgeries in the Netherlands

6.27 Dec 08, 2023: Sight Sciences Announces the Acceptance for Publication of GEMINI 2, a Three Year, Prospective, Multicenter Trial Demonstrating Sustained, Significant IOP and Medication Reductions Enabled with the OMNI Surgical System Technology

6.28 Nov 01, 2023: 6-Year Data Published in Journal of Glaucoma Demonstrates Effective, Sustained Reduction in Intraocular Pressure with iTrack Canaloplasty

6.29 Oct 31, 2023: iSTAR Medical Conducts First MINIject Surgeries in Ireland, Expanding Commercial Rollout in Europe

6.30 Oct 24, 2023: Ocular Therapeutix to Report Third Quarter 2023 Financial Results

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Glaucoma Surgery Devices – Pipeline Products by Stage of Development

Glaucoma Surgery Devices – Pipeline Products by Segment

Glaucoma Surgery Devices – Pipeline Products by Territory

Glaucoma Surgery Devices – Pipeline Products by Regulatory Path

Glaucoma Surgery Devices – Pipeline Products by Estimated Approval Date

Glaucoma Surgery Devices – Ongoing Clinical Trials

Glaucoma Surgery Devices Companies – Pipeline Products by Stage of Development

Glaucoma Surgery Devices – Pipeline Products by Stage of Development

Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview

Sollevio – Product Status

Sollevio – Product Description

Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview

XEN Gel Stent – ab externo – Product Status

XEN Gel Stent – ab externo – Product Description

Allergan Ltd – Ongoing Clinical Trials Overview

XEN Gel Stent – ab externo – Analysis of Efficacy and Safety of Ab Externo XEN Gel Stent Implantation in the Treatment of Glaucoma

Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Pressure Monitoring System – Product Status

Intraocular Pressure Monitoring System – Product Description

Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

VisiPlate – Product Status

VisiPlate – Product Description

Chongqing Migos Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Glaucoma Surgery Device – Product Status

Glaucoma Surgery Device – Product Description

Ciliatech Therapeutics AG Pipeline Products & Ongoing Clinical Trials Overview

Cilio-Scleral Inter-Positioning Device (CID) – Product Status

Cilio-Scleral Inter-Positioning Device (CID) – Product Description

Ciliatech Therapeutics AG – Ongoing Clinical Trials Overview

Cilio-Scleral Inter-Positioning Device (CID) – Monocentre, Observational Clinical Study Evaluating the Efficacy and Safety of a Novel Interposition Supraciliary Implant in Glaucoma Surgery

Cilio-Scleral Inter-Positioning Device (CID) – Multicentre, Non-randomised Clinical Study Evaluating the Efficacy and Safety of Cilioscleral Interposition Device v2.2 in Glaucoma Surgery

Cilio-Scleral Inter-Positioning Device (CID) – Non Randomised Mono-centered Study to Evaluate Safety and Efficacy of a Novel Cilioscleral Interposition Device (CID) SV22 in Glaucoma Patients Refractory to Topical Therapy

Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview

CorNeat eShunt – Product Status

CorNeat eShunt – Product Description

Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview

Therapeutic Ultrasound Device – Glaucoma – Product Status

Therapeutic Ultrasound Device – Glaucoma – Product Description

Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Titan Shunt – Product Status

Titan Shunt – Product Description

Geuder AG Pipeline Products & Ongoing Clinical Trials Overview

Microsystem Implant – Product Status

Microsystem Implant – Product Description

Glaucot Teknoloji AS Pipeline Products & Ongoing Clinical Trials Overview

GlaucoT – Product Status

GlaucoT – Product Description

Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview

iStent Infinite Trabecular Micro-Bypass System – Product Status

iStent Infinite Trabecular Micro-Bypass System – Product Description

Glaukos Corp – Ongoing Clinical Trials Overview

iStent Infinite Trabecular Micro-Bypass System – A Prospective, Multicenter Study of the Glaukos iStent Infinite Trabecular Micro-Bypass System Model iS3 in Subjects with Mild to Moderate Primary Open-angle Glaucoma

iStent Infinite Trabecular Micro-Bypass System – A Prospective, Randomized, Controlled, Comparative Multicenter Clinical Study of Glaukos Trabecular Micro-Bypass System Model iS3 Infinite Vs. Hydrus in Adult Subjects with Primary Open-Angle Glaucoma (POAG)

Health Guard Biomed (Suzhou) Biomedical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Hisiwei – Product Status

Hisiwei – Product Description

HiSilicon (Suzhou) Biomedical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

MicroCOGO – Product Status

MicroCOGO – Product Description

PassCOGO – Product Status

PassCOGO – Product Description

Iantrek Inc Pipeline Products & Ongoing Clinical Trials Overview

CycloPen Cyclodialysis System – Product Status

CycloPen Cyclodialysis System – Product Description

Iantrek Inc – Ongoing Clinical Trials Overview

CycloPen Cyclodialysis System – An Observational Registry Study of Safety and Effectiveness Outcomes Through 24 Months Postoperatively Following CycloPen Micro-Interventional Cyclodialysis System Procedures in Patients with Open Angle Glaucoma

InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview

PreserFlo MicroShunt – Product Status

PreserFlo MicroShunt – Product Description

InnFocus Inc – Ongoing Clinical Trials Overview

PreserFlo MicroShunt – Evaluation of Minimal Invasive Glaucoma Surgery: Trabeculectomy Vs. Xen Vs. Preserflo Randomized Clinial Trial

PreserFlo MicroShunt – SIGHT study: Cost-effectiveness of InnFocus Microshunt (IMS) Implantation Versus Standard Trabeculectomy (TE)

PreserFlo MicroShunt – Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation – a Prospective Cohort Study at the Ophthalmology Department Klinikum Klagenfurt

iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview

Glaucoma Device – Product Status

Glaucoma Device – Product Description

iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview

MINIject – Product Status

MINIject – Product Description

STARflo MINI – Product Status

STARflo MINI – Product Description

STARflo Plus Glaucoma Implant – Product Status

STARflo Plus Glaucoma Implant – Product Description

iSTAR Medical SA – Ongoing Clinical Trials Overview

MINIject – A Prospective, Open, Multicenter Clinical Trial Evaluating the Efficacy and Safety of MINIject Combined with Cataract Surgery in Patients with POAG Uncontrolled by Topical Hypotensive Medications and Operable Age-related Cataract Diagnosis

MINIject – A Prospective, Open, Multicenter Study Analysing the Long-term Safety of MINIject Glaucoma Implants in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications

MINIject – Evaluate the Safety and Effectiveness of ISTAR Medical’s MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects with Primary Open-angle Glaucoma.

MINIject – STAR-LIFE: A Post-market Registry on MINIject

iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

IVMED-70 – Product Status

IVMED-70 – Product Description

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

Partially Degradable Glaucoma Stent – Product Status

Partially Degradable Glaucoma Stent – Product Description

Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

MACC-Based Device – Glaucoma Filtering – Product Status

MACC-Based Device – Glaucoma Filtering – Product Description

Liqid Medical (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview

iFlow – Product Status

iFlow – Product Description

iPortVR – Product Status

iPortVR – Product Description

OptiShunt V1 – Product Status

OptiShunt V1 – Product Description

OptiShunt V2 – Product Status

OptiShunt V2 – Product Description

Liqid Medical (Pty) Ltd – Ongoing Clinical Trials Overview

OptiShunt V1 – Glaucoma Treatment by Oculo-subarachnoid Shunt Insertion: Pilot Study

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

CellPlant Aqueous Stent – Product Status

CellPlant Aqueous Stent – Product Description

Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Glaucoma Drainage Device – Product Status

Glaucoma Drainage Device – Product Description

Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview

Drainage Viscoelastic Injectable Implant – Product Status

Drainage Viscoelastic Injectable Implant – Product Description

MicroOptx Inc Pipeline Products & Ongoing Clinical Trials Overview

Beacon Aqueous Microshunt (BAM) – Product Status

Beacon Aqueous Microshunt (BAM) – Product Description

Mingche Biotechnology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Minimally Invasive Glaucoma Drainage Tube – Product Status

Minimally Invasive Glaucoma Drainage Tube – Product Description

Myra Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

Calibreye System – Product Status

Calibreye System – Product Description

Myra Vision Inc – Ongoing Clinical Trials Overview

Calibreye System – Feasibility Clinical Evaluation of the Calibreye System

Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview

CaPRI Device – Product Status

CaPRI Device – Product Description

OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview

Deep Wave Trabeculoplasty Device – Product Status

Deep Wave Trabeculoplasty Device – Product Description

OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview

Aquashunt – Product Status

Aquashunt – Product Description

OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview

Lipshitz Macular Implant – Advanced Glaucoma – Product Status

Lipshitz Macular Implant – Advanced Glaucoma – Product Description

Purdue University Pipeline Products & Ongoing Clinical Trials Overview

Smart Drainage Device – Glaucoma – Product Status

Smart Drainage Device – Glaucoma – Product Description

Queen’s University Pipeline Products & Ongoing Clinical Trials Overview

Laser Adjustable Suture – Product Status

Laser Adjustable Suture – Product Description

Rheon Medical SA Pipeline Products & Ongoing Clinical Trials Overview

eyeWatch System – Product Status

eyeWatch System – Product Description

Rheon Medical SA – Ongoing Clinical Trials Overview

eyeWatch System – EyeTube in Combination with the eyeWatch Implant

eyeWatch System – Randomized Control Trial of the eyeWatch System as a First-line Surgical Treatment of Glaucoma vs. MMC-Trabeculectomy

Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview

OMNI Surgical System – Canal Viscodilation – Product Status

OMNI Surgical System – Canal Viscodilation – Product Description

VISCO 360 Viscosurgical System – Primary Open Angle Glaucoma – Product Status

VISCO 360 Viscosurgical System – Primary Open Angle Glaucoma – Product Description

Stanford University Pipeline Products & Ongoing Clinical Trials Overview

Suprachoroidal Spacer Implant – Product Status

Suprachoroidal Spacer Implant – Product Description

Suzhou Langmu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

AqueEel – Product Status

AqueEel – Product Description

AqueFish Glaucoma Stent – Product Status

AqueFish Glaucoma Stent – Product Description

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview

Direct Laser Trabeculoplasty System – Product Status

Direct Laser Trabeculoplasty System – Product Description

Glaucoma Implant – Product Status

Glaucoma Implant – Product Description

The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Toroidal Glaucoma Drainage Device – Product Status

Toroidal Glaucoma Drainage Device – Product Description

The University of Texas at Austin Division of Housing and Food Service Pipeline Products & Ongoing Clinical Trials Overview

Microfluidic Meshwork Implant – Product Status

Microfluidic Meshwork Implant – Product Description

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

Aqueous Humor Micro-Bypass Shunt – Product Status

Aqueous Humor Micro-Bypass Shunt – Product Description

Glaucoma Device – Product Status

Glaucoma Device – Product Description

University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview

Glaucoma Drainage Device Regulator – Product Status

Glaucoma Drainage Device Regulator – Product Description

University of Florida Pipeline Products & Ongoing Clinical Trials Overview

Venting Shunt – Glaucoma – Product Status

Venting Shunt – Glaucoma – Product Description

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

Integrated Magnetoelastic Actuator – Product Status

Integrated Magnetoelastic Actuator – Product Description

University of Oslo Pipeline Products & Ongoing Clinical Trials Overview

MIGS Device – Product Status

MIGS Device – Product Description

Vivid White Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

VividFlo Glaucoma Implant (VW-51) – Product Status

VividFlo Glaucoma Implant (VW-51) – Product Description

Vivid White Pty Ltd – Ongoing Clinical Trials Overview

VividFlo Glaucoma Implant (VW-51) – A Prospective Multicentre Pivotal Clinical Study to Demonstrate the Efficacy and Safety of the VividWhite Glaucoma Implant (VW-51) for the Treatment of Glaucoma.

Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Pneumatic Trabeculoplasty System – Product Status

Pneumatic Trabeculoplasty System – Product Description

Glossary

Figures

Glaucoma Surgery Devices – Pipeline Products by Stage of Development

Glaucoma Surgery Devices – Pipeline Products by Segment

Glaucoma Surgery Devices – Pipeline Products by Territory

Glaucoma Surgery Devices – Pipeline Products by Regulatory Path

Glaucoma Surgery Devices – Pipeline Products by Estimated Approval Date

Glaucoma Surgery Devices – Ongoing Clinical Trials

Frequently asked questions

Glaucoma Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Glaucoma Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Glaucoma Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Glaucoma Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.